SECAUCUS, N.J.,
Aug. 14,
2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX),
the world's leading provider of diagnostic information services,
today announced that its Board of Directors declared a quarterly
cash dividend of $0.71 per share,
payable on October 23, 2023 to shareholders of
record of Quest Diagnostics common stock on October 6,
2023.
About Quest Diagnostics
Quest Diagnostics empowers
people to take action to improve health outcomes. Derived from the
world's largest database of clinical lab results, our diagnostic
insights reveal new avenues to identify and treat disease, inspire
healthy behaviors, and improve health care management. Quest
annually serves one in three adult Americans and half the
physicians and hospitals in the United
States, and our nearly 50,000 employees understand that, in
the right hands and with the right context, our diagnostic insights
can inspire actions that transform lives.
www.QuestDiagnostics.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-301900166.html
SOURCE Quest Diagnostics